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The mouse vomeronasal organ (VNO) is a chemosensory structure that detects
both hetero- and conspecific social cues. Based on largely monogenic expression of
either type 1 or 2 vomeronasal receptors (V1Rs/V2Rs) or members of the formyl
peptide receptor (FPR) family, the vomeronasal sensory epithelium harbors at least
three neuronal subpopulations. While various neurophysiological properties of both
V1R- and V2R-expressing neurons have been described using genetically engineered
mouse models, the basic biophysical characteristics of the more recently identified
FPR-expressing vomeronasal neurons have not been studied. Here, we employ a
transgenic mouse strain that coexpresses an enhanced variant of yellow fluorescent
protein together with FPR-rs3 allowing to identify and analyze FPR-rs3-expressing
neurons in acute VNO tissue slices. Single neuron electrophysiological recordings allow
comparative characterization of the biophysical properties inherent to a prototypical
member of the FPR-expressing subpopulation of VNO neurons. In this study, we provide
an in-depth analysis of both passive and active membrane properties, including detailed
characterization of several types of voltage-activated conductances and action potential
discharge patterns, in fluorescently labeled vs. unmarked vomeronasal neurons. Our
results reveal striking similarities in the basic (electro) physiological architecture of both
transgene-expressing and non-expressing neurons, confirming the suitability of this
genetically engineered mouse model for future studies addressing more specialized issues
in vomeronasal FPR neurobiology.
Keywords: vomeronasal receptor, formyl peptide receptor, vomeronasal organ, sensory neurons, VNO, olfaction
INTRODUCTION
For mammals, the sense of smell is crucial to interact adequately
with their environment. Fundamental information about hetero-
and conspecifics, such as identity, social or reproductive state,
is gathered by the olfactory system. In most mammals, this
system consists of up to four anatomically and functionally
distinct subsystems: the main olfactory system (Firestein, 2001;
Mombaerts, 2004), the Grueneberg ganglion (Fuss et al., 2005;
Koos and Fraser, 2005; Roppolo et al., 2006; Brechbühl et al.,
2008; Schmid et al., 2010), the septal organ of Masera (Adams,
1992; Ma et al., 2003) and the vomeronasal organ (VNO). The
VNO is a bilateral tubular structure located at the base of the
nasal septum. Vomeronasal sensory neurons (VSNs) are highly
sensitive chemoreceptors thought to primarily detect semiochem-
icals and other social cues (Leinders-Zufall et al., 2000; Dulac
and Torello, 2003; Spehr et al., 2006; Ferrero et al., 2013).
VSNs project single unbranched axons to the accessory olfactory
bulb (AOB). To date, members of at least four chemorecep-
tor gene families are expressed in VSNs: the V1r (Dulac and
Axel, 1995) and V2r (Herrada and Dulac, 1997; Matsunami
and Buck, 1997; Ryba and Tirindelli, 1997) families, with more
than 100 functional members each, a few odorant receptors
(Lévai et al., 2006), and the recently discovered formyl pep-
tide receptor (FPR)-related sequence (Fpr-rs) family of putative
chemoreceptor genes. The Fpr-rs family comprises 7 members,
5 of which (Fpr-rs1, rs3, rs4, rs6 and rs7) are predominantly
or exclusively expressed in subsets of VSNs (Liberles et al.,
2009; Rivière et al., 2009; Chamero et al., 2012). As key medi-
ators of leukocyte chemotaxis, FPR1 and FPR-rs2 receptor pro-
teins are expressed in immune cells such as granulocytes and
monocytes (Rivière et al., 2009; He et al., 2013) where they
serve crucial functions in host defense against pathogens by
detecting microbe- and/or host-derived inflammation-associated
metabolites (Migeotte et al., 2006; Le et al., 2007; Soehnlein and
Lindbom, 2010). However, neither FPR1 nor FPR-rs2 was found
transcribed in mouse VSNs (Liberles et al., 2009; Rivière et al.,
2009).
Vomeronasal sensory neurons expressing members of the V1R
family of G protein-coupled receptors are located in the more
apical part of the vomeronasal sensory epithelium. These neu-
rons co-express the G-protein α-subunit Gαi2 and project to
the anterior part of the AOB (Belluscio et al., 1999; Rodriguez
et al., 1999). Functionally, V1R neurons respond to sulfated
steroids and to a variety of other secreted ethologically relevant
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small semiochemicals (Leinders-Zufall et al., 2000; Boschat et al.,
2002; Novotny, 2003; Nodari et al., 2008; Isogai et al., 2011). By
contrast, V2R expression is restricted to VSNs in the more basal
Gαo-positive layer (Martini et al., 2001; Matsuoka et al., 2001;
Dulac and Torello, 2003). V2R neurons predominantly detect
peptides/small proteins (Leinders-Zufall et al., 2004; Chamero
et al., 2007; Kimoto et al., 2007; Ferrero et al., 2013; Kaur et al.,
2014) and project to the posterior region of the AOB. For FPR-
rs3 expressing neurons, we recently described axonal projections
to the rostral AOB (Dietschi et al., 2013), the target region of V1R
neurons.
The single Fpr-rs gene cluster is adjacent to a stretch of
more than 30 V1/2r genes. However, neither V1rs, nor V2rs
share significant sequence homology with vomeronasal Fpr-
rs genes. Liberles and coworkers suggested that vomeronasal
Fprs evolved from recent gene duplications and positive selec-
tion in the rodent lineage (Liberles et al., 2009). Together
with recent functional data obtained from recombinant FPR
expression (Bufe et al., 2012), these considerations argue for
a neofunctionalization of vomeronasal Fpr-rs genes. Their pre-
dicted seven-transmembrane topology, their selective, punctate
and monogenic vomeronasal expression pattern, and their local-
ization in microvillous dendritic VSN endings (Liberles et al.,
2009; Rivière et al., 2009), however, strongly suggest a functional
role of FPR-rs in vomeronasal chemosignaling. Interestingly,
while Fpr-rs1 is coexpressed with Gαo in basal sensory neurons,
the remaining vomeronasal Fpr-rs genes all coexpress Gαi2 in
the apical layer of the VNO neuroepithelium (Liberles et al.,
2009; Munger, 2009; Rivière et al., 2009). Vomeronasal sensory
neurons are activated in situ by formylated peptides and vari-
ous other antimicrobial/inflammatory modulators (Rivière et al.,
2009; Chamero et al., 2011) and heterologously expressed FPR-
rs proteins retain agonist spectra that share some similarities to
immune system FPRs (Rivière et al., 2009). However, the exact
biological role of vomeronasal FPRs remains to be determined.
To address the neurobiological function of vomeronasal FPRs
experimentally, a detailed physiological characterization of Fpr-rs
neurons in their native environment is mandatory. Genetically
modified animals in which the receptor identity of a given
chemosensory neuron is marked by coexpression of a fluorescent
reporter have proven particularly fruitful in the analysis of
olfactory signaling (Boschat et al., 2002; Bozza et al., 2002;
Grosmaitre et al., 2006, 2009; Oka et al., 2006; Ukhanov et al.,
2007; Leinders-Zufall et al., 2009; Pacifico et al., 2012). Here,
we describe a transgenic mouse strain that expresses FPR-
rs3 together with a fluorescent marker (Fpr-rs3-i-Venus). This
mouse model allows optical identification and subsequent phys-
iological analysis of FPR-rs3-expressing neurons in acute VNO
tissue slices. Using single neuron patch-clamp recordings, we
thus provide an in-depth electrophysiological characterization
of the basic biophysical properties inherent to a prototypical
member of the FPR-expressing subpopulation of VNO neu-
rons. Our analysis spans several types of voltage-activated con-
ductances as well as action potential discharge parameters in
both fluorescently labeled and control VSNs. Our data reveal a
number of physiological similarities between FPR-rs3-expressing
and non-expressing neurons. Together, these results confirm
the suitability of Fpr-rs3-i-Venus mice for future studies of
vomeronasal FPR neurobiology and, in addition, these find-
ings indicate that the FPR expression does not confer a dis-




All animal procedures were in compliance with local and
European Union legislation on the protection of animals used
for experimental purposes (Directive 86/609/EEC) and with
recommendations put forward by the Federation of Euro-
pean Laboratory Animal Science Associations (FELASA). Both
C57BL/6 mice (Charles River Laboratories, Sulzfeld, Germany)
and Fpr-rs3-i-Venus mice were housed in groups of both sexes at
room temperature on a 12 h light/dark cycle with food and water
available ad libitum. Experiments used young adults of either sex.
We did not observe obvious gender-dependent differences.
TRANSGENIC MICE
The transgene (Fpr-rs3-i-Venus) contains the FPR-rs3 coding
sequence followed by an internal ribosome entry site (IRES),
and the coding sequence for tau-Venus, a fusion between the
microtubule-associated protein tau and Venus yellow fluorescent
protein (Nagai et al., 2002). These coding sequences are under
the control of the H element followed by the MOR28 promoter
(Serizawa et al., 2006; modified by and generously provided
by P. Feinstein). The Fpr-rs3-i-Venus transgene was isolated on
gel after BssHII digestion and purified using the QIAquick®
Gel extraction kit (QIAGEN, Hilden, Germany). The trans-
gene was injected into the pronuclei of fertilized C57BL6/DBA2
mouse oocytes following standard procedures. Four founders
carrying the transgene were obtained. One of these founder
animals expressed the transgene in VSNs and was, thus, used
to start the colony. Backcrossed to C57BL/6J, mice were kept
hemizygous. Wild type and transgenic mice had no obvious
differences in size, weight, fertility, life expectancy or food
consumption.
CHEMICALS AND SOLUTIONS
The following solutions were used: (S1) 4-(2-Hydroxy-
ethyl)piperazine-1-ethanesulfonic acid (HEPES) buffered
extracellular solution containing (in mM) 145 NaCl, 5 KCl,
1 CaCl2, 1 MgCl2, 10 HEPES; pH = 7.3 (adjusted with
NaOH); osmolarity = 300 mOsm (adjusted with glucose).
(S2) Oxygenated (95% O2, 5% CO2) extracellular solution
containing (in mM) 125 NaCl, 25 NaHCO3, 5 KCl, 1 CaCl2,
1 MgSO4, 5 BES; pH = 7.3; osmolarity = 300 mOsm. (S3)
solution containing (in mM) 144 NaCl, 5 KCl, 1 TEACl, 1 CaCl2,
1 MgCl2, 10 HEPES, pH 7.3; osmolarity = 300 mOsm. (S4)
solution containing (in mM) 134 NaCl, 5 KCl, 1 TEACl, 1 CaCl2,
1 MgCl2, 10 HEPES, 10 4-AP, pH 7.3; osmolarity = 300 mOsm.
(S5) solution containing (in mM) 110 NaCl, 5 KCl, 25 TEACl,
1 CaCl2, 1 MgCl2, 10 HEPES, 10 4-AP, pH 7.3; osmolarity
= 300 mOsm. (S6) solution containing (in mM) 115 NaCl,
25 TEACl, 1, 1 MgCl2, 10 HEPES, 10 4-AP, pH 7.3; osmolarity
= 300 mOsm. (S7) solution containing (in mM) 105 NaCl,
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25 TEACl, 5 mM BaCl2, 1 MgCl2, 10 HEPES, 10 4-AP, pH 7.3;
osmolarity = 300 mOsm. (S8) Pipette solution containing (in
mM) 143 KCl, 2 KOH, 1 EGTA, 0.3 CaCl2 (free Ca2+ = 110 nM),
10 HEPES, 2 MgATP, 1 NaGTP; pH = 7.1 (adjusted with KOH);
osmolarity = 290 mOsm. (S9) Pipette solution containing (in
mM) 133 CsCl, 10 NaCl, 2 CsOH, 1 EGTA, 0.3 CaCl2 (free
Ca2+ = 110 nM), 10 HEPES, 1 MgATP, 1 NaGTP; pH = 7.1
(adjusted with CsOH); osmolarity = 290 mOsm.
Free Ca2+ and Mg2+ concentrations were calculated using
WEBMAXC STANDARD1. If not stated otherwise, chemicals
were purchased from Sigma (Schnelldorf, Germany). ω-agatoxin
IVa and ω-conotoxin GVIA were purchased from Biotrend
(Zurich, Switzerland). Stimuli and pharmacological agents were
applied from air pressure-driven reservoirs via an 8-in-1 multi-
barrel “perfusion pencil” (Science Products, Hofheim, Germany;
Veitinger et al., 2011).
CRYOSECTIONS
For preparation of cryosections, the VNO was fixed in PBS
containing 4% paraformaldehyde (2 h; 4◦C), decalcified overnight
in 0.5 M EDTA (4◦C) and cryoprotected in PBS containing 30%
sucrose (4◦C). The dehydrated VNO was embedded in Tissue
Freezing Medium and sectioned at 20 µm on a Leica CM1950
cryostat (Leica Biosystems, Nussloch, Germany).
VIBRATOME SECTIONS
Acute vomeronasal tissue sections were prepared as previously
described (Hagendorf et al., 2009; Spehr et al., 2009). Briefly, mice
were sacrificed by brief exposure to CO2 followed by decapitation
using sharp surgical scissors. The lower jaw and the soft palate
were removed allowing access to the vomeronasal capsule. After
removal of the cartilage, the dissected VNO was embedded in 4%
low-gelling temperature agarose and coronal slices (150–200 µm)
were cut in ice-cold oxygenated extracellular solution (S2) using a
Leica VT1000S vibratome (speed: 3.5 a.u. = 0.15 mm/s; frequency:
7.5 a.u. = 75 Hz; amplitude: 0.6 mm; Leica Biosystems). Sections
were transferred to a submerged, oxygenated (S2) and chilled
storage chamber until use.
IMMUNOHISTOCHEMISTRY
Blocking was performed for 1 h in PBS containing 2% goat serum,
1% gelatine and 0.2% Triton X-100 (blocking solution). Sections
were then incubated overnight at 4◦C with primary antibody sera
(1:500 rabbit anti-V2R2; 1:200 rabbit anti-FPR-rs3) in blocking
solution, washed in PBS containing 0.05% Triton-X 100 (3 ×
10 min, 1 × 30 min), and incubated for 1 h with Alexa®Fluor
secondary antibodies (1:500). Excess antibodies were removed by
washing in PBS containing 0.05% Triton-X 100 (3× 10 min, 1×
30 min). To control for nonspecific staining, experiments in which
the primary antibodies were omitted were performed in parallel
with each procedure.
ELECTROPHYSIOLOGY
Vomeronasal organ slices were transferred to a recording cham-
ber (Luigs & Neumann, Ratingen, Germany) on an upright
1Available at http://www.stanford.edu/~cpatton/webmaxcS.htm
fixed-stage scanning confocal microscope (TCS SP5 DM6000CFS,
Leica Microsystems) equipped with a 20x/1.0 NA water immer-
sion objective (HCX APO L, Leica Microsystems) as well as a
cooled a CCD-camera (DFC360FX, Leica Microsystems). Slices
were continuously superfused with oxygenated S2 (∼3 ml/min;
gravity flow; RT). Patch pipettes (4–7 MΩ) were pulled from
borosilicate glass capillaries (1.50 mm OD/0.86 mm ID; Science
Products) on a PC-10 micropipette puller (Narishige Instru-
ments, Tokyo, Japan), fire-polished (MF-830 Microforge; Nar-
ishige Instruments) and filled with pipette solution (S8 or S9)
depending on experimental design. An agar bridge (150 mM
KCl) connected reference electrode and bath solution. An EPC-
10 amplifier controlled by Patchmaster 2.67 software (HEKA
Elektronik, Lambrecht/Pfalz, Germany) was used for data acqui-
sition. We monitored and compensated pipette and membrane
capacitance as well as series resistance. Only neurons exhibit-
ing small and stable access resistances (≤3% of Rinput; change
<20%) were used for analysis. Liquid junction potentials were
calculated using JPCalcW software (Barry, 1994) and corrected
online. If not stated otherwise, signals were low-pass filtered
(analog 3- and 4-pole Bessel filters (–3 dB); adjusted to 1/3–1/5 of
the sampling rate (5–10 kHz, depending on protocol)). Between
recordings, holding potential (Vhold) was −60 mV. All electro-
physiological data were recorded in whole-cell configuration at
room temperature.
DATA ANALYSIS
All data were obtained from independent experiments performed
on at least 3 days using at least three different animals. Individual
numbers of cells/experiments (n) are denoted in figure legends.
If not stated otherwise, results are presented as means ± SEM.
Statistical analyses were performed using paired or unpaired
t-tests or one-way ANOVA with Tukey’s HSD post hoc test.
Tests and corresponding p-values that report statistical signifi-
cance are individually specified in figure legends. Drug sensitiv-
ity of voltage-gated K+ (Kv) currents was examined based on
an “additive” drug exposure regime, i.e., TEA (1 mM), 4-AP
(10 mM), and TEA (25 mM) were sequentially applied and the
inhibitor-sensitive currents were isolated by subsequent “offline”
subtraction from each preceding recording.
Electrophysiological data were analyzed offline using Patch-
Master 2.67 (HEKA Elektronik), IGOR Pro 6.3 (WaveMetrics,
Lake Oswego, OR) and Excel (Microsoft, Seattle, WA) software.
Activation curves were fitted by the Hill equation to calculate the
membrane potential of half-maximal activation (V1/2). Current
activation time constants (τ) were calculated by fitting individual
traces to monoexponential functions I(t) = I1 [exp (−t/τ)] + I0.
RESULTS
TRANSGENIC EXPRESSION OF Fpr-rs3-i-VENUS IN A SUBSET
OF NEURONS IN THE MOUSE VNO
To analyze the biophysical properties inherent to a prototypical
member of the FPR-expressing neurons, we engineered transgenic
mice that express Fpr-rs3-i-Venus in a subset of olfactory sensory
neurons (OSNs). Using standard transgenic techniques (see sec-
tion materials and methods), we generated such a mouse strain
in which FPR-rs3 is coexpressed with tau-Venus, an enhanced
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FIGURE 1 | Generation and characterization of the Fpr-rs3-i-Venus
transgenic mouse line. (A) Schematic of the transgene that includes an OR
promoter/enhancer, followed by the coding sequence of FPR-rs3 and a
polycistron that drives the tau-Venus fluorophore. (B) Confocal image of a
coronal VNO cryosection showing sparsely distributed fluorescently labeled
FPR-rs3+ VSNs (green) in the sensory neuroepithelium. (C) Confocal image
displaying a coronal VNO cryosection immunostained with an antibody
against V2R2 (red), a family-C V2R expressed in most basal VSNs. (D) Overlay
of FPR-rs3 tau-Venus fluorescence and anti-V2R2 staining shows no
co-localization of apically located FPR-rs3+ and basal V2R2 expressing
neurons. (E) Higher magnification of the boxed area in (D) illustrating the
absence of overlapping fluorescence. (F) Confocal image of a VNO
cryosection showing distinct green fluorescent FPR-rs3+ sensory neurons
(green). (G) Confocal image displaying the same area as in (F) stained against
the FPR-rs3 protein (red). (H) Overlay of tau-Venus fluorescence and antibody
staining against the FPR-rs3 protein. Note that all transgene-positive cells also
express FPR-rs3 (yellow). Scale bars, 50 µm (B–D), 10 µm (E) and
20 µm (F–H).
variant of yellow fluorescent protein (Nagai et al., 2002) fused
to the microtubule-associated protein tau (Figure 1A). Four
founders were obtained. Two of them expressed the transgene in
OSNs, and one of them in VSNs. We focused our attention on
this latter line, given its exclusive vomeronasal expression pattern.
Neither hemi-, nor homozygous Fpr-rs3-i-Venus mice from this
line showed any obvious aberrant phenotype.
In coronal VNO tissue slices, a subpopulation of VSNs
is fluorescently labeled (81 out of 11,416 neurons (∼0.7%);
Figures 1B,F) indicating expression of the Fpr-rs3-i-
Venus transgene. Fluorescent neurons are morphologically
indistinguishable from unlabeled VSNs. Their somata appear
to be predominantly located in the apical layer of the
neuroepithelium (Figure 1B). Among the five vomeronasal FPRs,
FPR-rs3, 4, 6 and 7 are expressed in the more apical Gαi2-positive
layer of the VNO sensory epithelium, whereas FPR-rs1 is located
in more basal Gαo-expressing neurons (Liberles et al., 2009;
Rivière et al., 2009). To investigate layer-specific expression of
the Fpr-rs3-i-Venus transgene we immunostained coronal VNO
cryosections from hemizygous mice with an antibody against
V2R2 (α-V2R2; specific for family-C V2Rs that are broadly
expressed in the great majority of basal VSNs; Figures 1C–E;
Martini et al., 2001; Silvotti et al., 2007). We never observed
colabeling of transgene-expressing and V2R2-immunopositive
VSNs (n = 79) confirming layer-specific expression of the FPR-rs3
transgene in apical VSNs. Immunostaining with an anti-FPR-rs3
antibody (Rivière et al., 2009; Dietschi et al., 2013) revealed 424
out of 53,284 FPR-rs3+ VSNs (0.79%), an expression level within
the previously reported range between 0.4% and 0.8% (Rivière
et al., 2009; Dietschi et al., 2013). Moreover, all transgene-positive
cells (n = 225) also express the FPR-rs3 protein (Figures 1F–H).
Some FPR-rs3-immunopositive neurons (199 out of 424 cells)
did not show detectable Venus fluorescence, consistent with the
presence of VSNs endogenously expressing FPR-rs3.
Frontiers in Neuroanatomy www.frontiersin.org November 2014 | Volume 8 | Article 134 | 4
Ackels et al. FPR-rs3-expressing vomeronasal neurons
FIGURE 2 | Passive membrane properties of FPR-rs3+ VSNs.
(A) Confocal image (maximum projection) of a 150 µm acute coronal VNO
tissue slice showing the distribution of fluorescent FPR-rs3 tau-Venus+
neurons (green) in the vomeronasal sensory epithelium. Fluorescent axon
bundles are visible within the basal lamina. (B) FPR-rs3 tau-Venus+ neurons
exhibit a single apical dendrite ending in a knob-like structure at the luminal
border. Whole cell patch-clamp recordings were performed from the VSN
soma. (C) Membrane capacitance and (D) input resistance (Rinput) are
similar for both control and FPR-rs3+ neurons (n = 21). (E) Membrane time
constant (τmembrane) of control neurons compared to FPR-rs3+ cells shows
no significant difference (n = 21). Data are mean ± SEM. Blood vessel (BV),
lumen (L), patch pipette (PP), sensory epithelium (SE). Scale bars,
50 µm (A), 10 µm (B).
PASSIVE MEMBRANE PROPERTIES OF FPR-rs3+ VSNs
The passive membrane properties of a neuron determine its
basic electrophysiological characteristics and, thus, control its
individual stimulus-response function. For FPR-rs expressing
vomeronasal neurons, these critical physiological parameters are
unknown. Using Fpr-rs3-i-Venus mice, we performed whole-cell
patch-clamp recordings from optically identified, fluorescently
labeled FPR-rs3-expressing neurons in acute VNO tissue slices
(Figures 2A,B). For quantitative comparison, we additionally
performed a series of control experiments in randomly chosen
VSNs from C57BL/6 wild type mice.
Passive membrane properties (i.e., input resistance (Rinput),
membrane capacitance (Cmem), and membrane time constant
(τmem)) were obtained immediately after membrane rupture.
Treated, to a first approximation, as a “biological constant”
with a value of ∼1 µF/cm2 (Gentet et al., 2000), Cmem was
determined using a square pulse (5 mV, 10 ms) routine.
Transgene-positive (FPR-rs3+) neurons revealed an average Cmem
value of 5.96 ± 0.49 pF (n = 21), similar to data obtained from
control VSNs (5.24 ± 0.38 pF; n = 21; Figure 2C). We next
determined Rinput at the VSN soma by measuring the steady-
state voltage response to a current step of defined amplitude. The
average somatic Rinput of FPR-rs3+ neurons was 3.15 ± 0.49 G
(n = 21; Figure 2D). This large value resembles Rinput measure-
ments from control VSNs (3.29 ± 0.43 G; n = 21), suggesting
that FPR-rs3+ neurons share the extraordinary sensitivity of
V1/2R-expressing VSNs (Liman and Corey, 1996; Shimazaki et al.,
2006; Hagendorf et al., 2009). Linear passive voltage responses
were also used to estimate τmem from monoexponential fits to
the voltage responses (from onset to steady state). We obtained
relatively slow τmem values of 26.79 ± 2.25 ms (n = 21) in FPR-
rs3+ neurons vs. 24.29 ± 1.57 ms (n = 21) in control neurons
(Figure 2E).
Together, these results describe different passive membrane
parameters of FPR-rs3+ neurons. Moreover, these data show that
the passive electrical properties of FPR-rs3 expressing VSNs do
not significantly differ from control neurons, suggesting (a) that
FPR-rs expressing VSNs are not segregated or isolated from the
“general” VSN population; and (b) that transgene expression per
se does not perturb the passive biophysical properties of FPR-rs3+
neurons.
ACTIVE MEMBRANE PROPERTIES OF FPR-rs3+ NEURONS
Next, we examined the active membrane properties of FPR-
rs3+ neurons. A hallmark of VSNs is that depolarizing current
injection of only a few picoamperes triggers repetitive action
potential discharge (Liman and Corey, 1996; Shimazaki et al.,
2006). This also holds true for FPR-rs3+ neurons (Figure 3A).
Current-clamp recordings from fluorescently labeled VSNs show
repetitive spiking in response to depolarizing current steps of
2–24 pA. Spontaneous activity (measured at 0 pA current injec-
tion) was 2.37 ± 0.54 Hz (n = 19) for FPRrs3+ neurons and
3.9 ± 1.08 Hz (n = 21) for control cells (Figure 3B, inset).
By plotting mean instantaneous spike frequencies as a function
of stationary current input (f -I curve; Figure 3B), response
saturation at amplitudes >20 pA becomes apparent (maximum
frequency f max = 14.5 ± 0.88 Hz (n = 19; FPR-rs3+ neurons) or
16.54 ± 1.17 Hz (n = 21; control VSNs)). Injection of negative
current into FPR-rs3+ neurons revealed a hyperpolarization-
activated rebound depolarization (“sag”; Figure 3Aiii), indicative
of Ih currents and, thus, HCN channel expression (Robinson
and Siegelbaum, 2003; Dibattista et al., 2008). Plotting the sag
potential amplitude (∆Vsag; Figure 3Aiii) as a function of peak
hyperpolarization reveals the threshold (< −75 mV) and volt-
age dependence of the sag (n = 5–23; Figure 3C), likely cor-
responding to an increase in HCN channel activation at more
negative membrane potentials. A similar voltage dependence
was observed for control cells (n = 5–32). In both FPR-rs3+
and control VSNs, we frequently observed rebound spikes upon
repolarization (Figure 3Aiii).
Next, we examined action potential discharge of FPR-rs3+
neurons. Figure 3Di depicts an averaged spike waveform and
shows schematically how different spike parameters were ana-
lyzed: spike amplitude was measured as the threshold-to-peak
distance, spike duration was calculated as the full duration at
half-maximum (FDHM), spike generating kinetics was measured
as the time-to-peak (TTP). All analyses were based on the first
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FIGURE 3 | Active membrane properties of FPR-rs3+ VSNs.
(A) Representative current clamp traces showing de- / hyperpolarization
and trains of (rebound) action potentials generated upon stepwise current
injection. Note the spontaneous activity measured at 0 pA current injection
(Aii). Injection of negative current produces a prominent voltage “sag”
most likely mediated by activation of HCN channels (Aiii). (B) Firing
frequency of control (n = 21) and FPR-rs3+ (n = 19) neurons as a function of
the injected current (Iinject). The gradual increase in firing rate is comparable
for control and FPR-rs3+ VSNs. Inset: Spontaneous spiking frequency at 0
pA current injection. Note that f -I curves have been “background-corrected”
using these values. (C) Voltage “sag” (∆Vsag, n = 3–32) as a function of the
peak membrane hyperpolarization (10 mV bins). ∆Vsag values of control and
FPR-rs3+ neurons show no statistical difference (p > 0.01, two-tailed
Student’s t-test). (D) Average spike waveform illustrating analysis
parameters (amplitude, time-to-peak (TTP), full duration at half-maximum
(FDHM; Di). Amplitude analysis of the first action potential for each current
injection step shows no difference between control and FPR-rs3+ cells
(Dii). TTP analysis reveals values in the same range for both cell
populations (Diii). Spike width (FDHM) is not significantly different
between control and FPR-rs3+ VSNs (Div). Data are mean ± SEM.
spike of a given train of action potentials (see Figure 3Ai). Our
results reveal an average amplitude of 72.24 ± 0.97 mV (n = 134)
for FPR-rs3+ neurons and 73.92 ± 0.87 mV (n = 172) for
control neurons (Figure 3Di). Average TTP values were 2.29
± 0.06 ms (FPR-rs3+ cells) and of 2.33 ± 0.09 ms (control
neurons), while FDHM was 3.65 ± 0.08 ms (FPR-rs3+ neurons)
and 3.67± 0.12 ms (control VSNs), respectively.
These data show that FPR-rs3 expressing VSNs exhibit rather
slow action potentials and, albeit an extraordinary sensitivity,
show a relatively narrow spike frequency coding range. Together,
these active membrane properties are shared by both FPR-rs3
expressing and control neurons.
VOLTAGE-GATED Na+ CURRENTS OF FPR-rs3+ NEURONS
In excitable cells, voltage-gated Na+ (NaV) channels are
primarily responsible for action potential initiation and impulse
propagation. Upon membrane depolarization, NaV channels
mediate the rapid Na+ influx that underlies the upstroke of the
action potential. However, the electrophysiological properties
of the nine homologous members of the NaV channel family
(NaV1.1 to NaV1.9) are not identical and even small differences
in NaV channel expression can have profound effects on
electrical excitability (Hille, 2001). Therefore, we next focused on
macroscopic voltage-activated Na+ currents (INav) in FPR-rs3+
neurons. Stepwise depolarizations from −120 mV to +70 mV
(30 ms duration; 5 mV increment) in absence and presence of
tetrodotoxin (TTX; Figure 4Ai–ii; Narahashi et al., 1966; Wu
and Narahashi, 1988) allowed pharmacological isolation of the
TTX-sensitive INav (Figure 4Aiii). Plotting peak INav density as
a function of membrane depolarization, the current-voltage
relationship (Figure 4B) reveals an activation threshold at
approximately −65 mV and a maximum current density of
−136.7 ± 14.1 pA/pF (n = 10). Similar values were recorded
from control VSNs (maximum INav = −157.5 ± 17.4 pA/pF; n =
20). Figure 4Ci illustrates the kinetics of channel gating during
a single depolarizing step in membrane potential (−30 mV). As
expected from relatively slow action potential firing in FPR-rs3+
neurons (Figure 3D), TTP analysis of INav reveals relatively slow
activation kinetics (1.86± 0.10 ms; n = 10; Figure 4Cii).
Next, we examined the voltage-dependence of TTX-
sensitive INav activation and inactivation in FPR-rs3+ neurons
(Figures 4D,E). Fitting normalized peak INav amplitudes vs.
voltage to a sigmoidal (Boltzmann) function demonstrates half-
maximal current activation upon depolarization to approximately
−50 mV (V1/2 = 48.6 mV; n = 9; Figure 4Ei). Steady-state INav
inactivation was analyzed upon depolarization to +20 mV,
preceded by prepulse steps to different potentials ranging
from −120 mV to 0 mV (30 ms duration; 5 mV increment;
Figure 4D). Again, offline subtraction of TTX-insensitive
currents (Figure 4Dii) from control recordings (Figure 4Di)
allowed pharmacological isolation of TTX-sensitive INav
(Figure 4Diii). Steady-state inactivation curves are derived
from inverse sigmoidal fits to normalized peak INav amplitudes
vs. prepulse voltage (Figure 4Eii) and reveal half-maximal
inactivation upon depolarization to V1/2 = −25 mV (n = 10).
Interestingly, at voltages ranging from approximately −60 mV
to −5 mV, activation and inactivation curves overlap, suggesting
coexpression of multiple NaV channel isoforms and/or a
substantial “window current”.
Together, these results demonstrate that FPR-rs3+ VSNs
express one or more NaV channel isoform(s) that exhibit rela-
tively slow activation upon membrane depolarization >−65 mV
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FIGURE 4 | Voltage-gated Na+ currents. (A) Representative traces from
whole-cell patch-clamp recordings of a TTX-sensitive fast activating Na+
current in FPR-rs3+ VSNs. (Ai) Voltage step recording under control
conditions (extracellular solution S1; intracellular solution S9) reveals a
voltage-dependent fast and transient inward current. (Aii) TTX treatment
(1 µM) strongly diminishes the current. Digitally subtracted trace
(control-TTX (Aiii)) reveals the TTX-sensitive voltage-gated Na+ current. (B)
Current-voltage relationships of TTX-sensitive Na+ currents isolated from
control and FPR-rs3+ neurons (control, n = 20; FPR-rs3+, n = 10; p > 0.01,
two-tailed Student’s t-test). (C) Example of a voltage-clamp recording
showing the fast activating transient inward current used for upstroke
kinetics analysis (Ci). TTP of the fast activating Na+ current upon
depolarization to −30 mV (control, n = 20; FPR-rs3+, n = 10; Cii).
(D) Representative traces showing Na+ channel steady-state inactivation
under control conditions (Di), in presence of TTX (Dii), and after digital
subtraction (control-TTX (Diii)). Prepulse steps from −120 mV to 0 mV
were applied to analyze inactivation (Diii, inset). (E) Normalized activation
(Ei) and steady-state inactivation (Eii) curves (peak current vs.
pulse/prepulse voltage). Data points were fitted using a sigmoidal
Boltzmann-type equation. Membrane voltage inducing half-maximal
activation and inactivation (V1/2) as indicated. Data are mean ± SEM.
with half-maximal and complete activation at ∼−50 mV and
−30 mV, respectively. Moreover, the slope of the steady-state
inactivation curve is relatively shallow, revealing that full channel
inactivation only occurs at positive potentials. Since all measured
parameters are similar to data recorded from control VSNs, our
data further substantiate the notion that that FPR-rs expressing
neurons do not constitute a biophysically segregated “outgroup”
of VSNs.
VOLTAGE-GATED K+ CURRENTS OF FPR-rs3+ NEURONS
To a large extent, Kv channels control electrical signaling
in excitable cells. Accordingly, the large and extended Kv
channel family is functionally diversified by alternative splicing,
oligomeric subunit assembly, and subcellular targeting (Jan and
Jan, 2012). As Kv channels are involved in regulating a wide range
of neuronal functions, such as setting the resting membrane
potential, dictating the duration and/or frequency of action
potentials, volume regulation, etc., we next characterized Kv
channel-mediated currents (IKv) in FPR-rs3+ neurons.
Activated by depolarization, outward flux of K+ repolarizes the
membrane and, thus, contributes to action potential termination
and, in some neurons, afterhyperpolarization. To isolate different
classes of IKv we used a pharmacological toolkit of several well-
described Kv channel inhibitors (Alexander et al., 2013). Depend-
ing on concentration, tetraethylammonium (TEA) functions as a
relatively selective inhibitor of big conductance Ca2+-dependent
K+ (BK) channels at low millimolar concentrations (Yellen,
1984), whereas substantially higher concentrations (25 mM) serve
as a nonselective “broadband” Kv channel blocker (Alexander
et al., 2013). In addition, 4-aminopyridine (4-AP) specifically
blocks A-type K+ currents in various neurons (Mei et al., 1995;
Amberg et al., 2003).
Under control conditions, stepwise depolarization from −100
to +85 mV (100 ms duration; 5 mV increment) triggered large
outward currents that essentially showed no sign of inactivation
(Figure 5A, inset). When steady-state currents were plotted as a
function of depolarization, the resulting current-voltage relation-
ship reveals IKv activation at approximately−30 mV (Figure 5A).
Linear regression from data points corresponding to full activa-
tion (+60 mV – +85 mV) indicates IKv reversal at ∼−65 mV.
When drug-sensitive currents were isolated by digital subtrac-
tion of blocker-insensitive from respective “control” recordings
(Figures 5B–D, insets; see section materials and methods), the
resulting current-voltage plots revealed no statistical differences
between FPR-rs3+ neurons and control VSNs (Figures 5B–D).
Somewhat surprisingly, currents isolated by 4-AP treatment did
not show a pronounced transient component typical for A-type
K+ currents. Interestingly, summation of the individual drug-
sensitive IKv components added up to almost 100% of control
currents (276.5 ± 31.1 pA/pF at +85 mV; n = 13; Figure 5E)
showing that a “cocktail” of 4-AP (10 mM) and TEA (25 mM) is
sufficient to block essentially all Kv channels in FPR-rs3+ neurons.
This pharmacological profile was statistically indistinguishable
from control VSNs.
Next, we investigated how the pharmacologically different Kv
channel populations shape action potential discharge in FPR-
rs3+ cells. Spikes were elicited and discharge parameters were
analyzed as described (Figures 3D, 5Fi). VSNs were challenged
with either TEA (1 mM) or 4-AP (10 mM). Spike amplitude
(Figure 5Fii) was not altered by either drug. Both Kv channel
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FIGURE 5 | Voltage-gated K+ currents and their role in action potential
firing. (A) Voltage-activated outward K+ currents under control conditions
(solution S1 including TTX (1 µM) and Cd2+ (200 µM) to isolate K+ currents).
Currents were induced by stepwise depolarization and measured during
steady-state. Current densities were calculated and plotted against voltage
(control, n = 10; FPR-rs3+, n = 13). (B) Outward currents sensitive to 1 mM
TEA (control-TEA; digital subtraction; n = 10). (C) Outward currents sensitive
to 10 mM 4-AP (control/TEA-4-AP; digital subtraction; n = 10). (D) Outward
currents sensitive to 25 mM TEA (control/TEA/4-AP-TEA; digital subtraction;
n = 10). (E) Quantification of outward currents. Maximum current densities
under control conditions (left bars; 292.5 ± 22.4 pA/pF at +85 mV, n = 10
(ctrl); 276.5 ± 31.1 pA/pF, n = 13 (FPR-rs3+)) and added drug sensitive current
densities (ctrl: 90.3 ± 9.1 pA/pF (1 mM TEA), 76.8 ± 7.9 pA/pF (10 mM 4-AP),
85.7 ± 11.2 pA/pF (25 mM TEA); FPR-rs3+: 78.9 ± 10.6 pA/pF (1 mM TEA),
77.5 ± 10.5 pA/pF (10 mM 4-AP), 99.8 ± 14.6 pA/pF (25 mM TEA)). Data are
mean ± SEM. (F) Representative spike waveform under control conditions
(solution S1 (Extra)) and in presence of TEA (1 mM) and 4-AP (10 mM; Fi).
Analysis parameters (amplitude, TTP, FDHM and spike duration) are depicted
schematically. Bar graphs illustrate the quantification of discharge
characteristics (Fii–v). *p < 0.01; two-way ANOVA with Tukey’s multiple
comparisons test. Data are mean ± SEM, number of cells as depicted inside
the bars.
inhibitors affected the upstroke dynamics (Figure 5Fiii). However,
while block of putative BK channels by TEA (1 mM) accelerated
the upstroke, inhibition of A-type currents prolonged the average
TTP. 4-AP treatment also prolonged the spike width (FDHM)
and, consequently, spike duration (Figure 5Fiv–v) whereas TEA
did not elicit such effects. The effects of 4-AP are significantly
more pronounced in FPR-rs3 expressing VSNs than in control
neurons (Figure 5Fiii–v).
In summary, these data demonstrate that multiple Kv channel
subunits are expressed in FPR-rs3+ neurons. These different
channel populations synergistically shape the firing properties of
FPR-rs3 expressing VSNs. Moreover, with the notable exception
of 4-AP-sensitive channel function during discharge, the Kv chan-
nel expression profile of FPR-rs3+ neurons is largely comparable
to control VSNs.
VOLTAGE-GATED Ca2+ CURRENTS OF FPR-rs3+ NEURONS
Voltage-gated Ca2+ (CaV) channels are integral constituents of
a neuron’s Ca2+ signaling toolkit (Berridge et al., 2003). As
such, they are key signal transducers that transform electrical
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impulses (depolarization) into a biochemically relevant signal
(Ca2+ influx) that regulates a wide variety of cellular events
(Catterall, 2000b; Clapham, 2007). We therefore investigated CaV
currents (ICav) in FPR-rs3+ neurons.
The ten functional vertebrate CaV channel subunits are
divided into three subfamilies (CaV1 to CaV3) that differ in
function and regulation (Triggle et al., 2006). Both within
and between subfamilies, individual CaV channel isoforms
are identified by their distinct biophysical properties and
pharmacological profiles (Catterall, 2000b; Alexander et al.,
2013). Thus, we isolated transient (T-type) currents mediated
by members of the CaV3 subfamily by digital subtraction of ICav
recorded in response to depolarizing voltage steps (−100 mV to
+45 mV; 100 ms duration; 5 mV increment) from two different
prepulse potentials (−100 mV and −25 mV, respectively;
Figure 6Ai, inset). Based on steady-state inactivation of CaV3
channels at −25 mV (Catterall et al., 2005), the fraction of low
voltage activated (LVA) Ca2+ channels becomes readily apparent
after subtraction (Figure 6Ai). As expected, these T-type currents
rapidly inactivate and the underlying activation and inactivation
kinetics become faster with increasing depolarization (Perez-
Reyes et al., 1998). The resulting current-voltage relationship
(Figure 6Aii) and normalized ICav activation curve (sigmoidal fit;
Figure 6Aiii) demonstrate an activation threshold of−60 mV and
half-maximal current activation upon depolarization to −40 mV
(V1/2 =−40.27 mV; n = 9), values typical for T-type currents.
Next, we investigated functional expression of high voltage
activated (HVA) CaV channels in FPR-rs3+ neurons. All four
members of the CaV1 subfamily are characterized by both long-
lasting and large (L-type) Ca2+ currents and high sensitivity
to dihydropyridines, such as nifedipine (Catterall et al., 2005).
Therefore, to examine L-type ICav, we recorded responses to depo-
larizing voltage steps (−100 mV to +85 mV; 100 ms duration;
5 mV increment) and isolated nifedipine-sensitive currents by
digital subtraction (Figure 6Bi). As expected for L-type currents,
isolated ICav shows relatively slow, though lasting activation upon
depolarization ≥−45 mV (Figure 6Bii). Half-maximal activa-
tion is observed upon more pronounced depolarization (V1/2 =
−26.06 mV; n = 7; Figure 6Biii).
Members of the CaV2 subfamily of HVA Ca2+ channels are
selectively sensitive to peptide neurotoxins from spider and cone
snail venoms (Catterall, 2000a). Using ω-conotoxin-GVIA, we
next isolated conotoxin-sensitive N-type ICav from FPR-rs3+ neu-
rons (Figure 6Ci). N-type currents activate upon depolarizations
≥−40 mV (Figure 6Cii). At approximately−25 mV, N-type ICav is
half-maximally activated (V1/2 =−25.46 mV; n = 7; Figure 6Ciii).
Surprisingly, recordings from control VSNs reveal substantially
larger conotoxin-sensitive currents (Figure 6Cii–iii). While T- and
L-type ICav in FPR-rs3+ VSNs did not significantly differ from
control neurons, maximum N-type current density was −24.05
± 2.37 pA/pF in fluorescently labeled cells (n = 7), but −36.96
± 6.50 pA/pF in control VSNs (n = 8). Moreover, half-maximal
activation in controls was shifted to more positive values (V1/2 =
−19.24 mV; n = 8; Figure 6Ciii).
A slight, though also significant difference between FPR-rs3+
and control neurons was observed for P/Q-type Ca2+ currents
that were pharmacologically isolated using ω-agatoxin IVA
(Randall and Tsien, 1995; Catterall, 2011). P/Q-type currents
revealed relatively slow activation and slight inactivation. Com-
pared to control recordings, both the current-voltage relationship
(Figure 6Dii) and the sigmoidal activation curve (Figure 6Diii)
of P/Q-type ICav in FPR-rs3+ neurons was left-shifted to more
negative potentials. Maximum current density, however, did
not significantly differ between FPR-rs3+ VSNs (−29.50 ± 3.31
pA/pF; n = 8) and control neurons (−31.46± 4.34 pA/pF; n = 5).
In summary, the above data show that FPR-rs3+ neurons
exhibit a variety of CaV currents, both LVA and HVA. Since both
N- and P/Q-type currents show somewhat different properties in
FPR-rs3 expressing VSNs, these two CaV2 channel isoforms might
play distinct roles in FPR-rs3+ neurophysiology.
DISCUSSION
For most mammals, the VNO is crucial for intra- and interspecific
chemical communication. While the basic biophysical properties
of both V1R- and V2R-expressing vomeronasal neurons have
been described (Liman and Corey, 1996; Trotier and Døving,
1996; Fieni et al., 2003; Shimazaki et al., 2006; Ukhanov et al.,
2007; Hagendorf et al., 2009), VSNs that express members of
the recently discovered family of vomeronasal FPR-rs proteins
(Liberles et al., 2009; Rivière et al., 2009) remain physiologically
unexplored. Here, we describe a transgenic mouse model (Fpr-
rs3-i-Venus) in which expression of one member of the FPR-rs
family (FPR-rs3) is marked by Venus fluorescence. This mouse
strain allows identification and electrophysiological analysis of
FPR-rs3-expressing neurons in acute VNO tissue slices. Thus,
we provide an in-depth analysis of both passive and active
membrane properties, including detailed characterization of sev-
eral types of voltage-activated conductances and action poten-
tial discharge patterns, in fluorescently labeled vs. unmarked
vomeronasal neurons. Our results reveal a number of similar-
ities, but also some differences in the basic (electro) physio-
logical architecture of transgene-expressing vs. non-expressing
neurons.
Vomeronasal transgene expression in Fpr-rs3-i-Venus mice
faithfully recapitulates the punctate apical expression pattern of
endogenous FPR-rs3 (Rivière et al., 2009; Dietschi et al., 2013).
Furthermore, bicistronic expression of the tau-Venus fusion pro-
tein additionally targets the fluorescent marker to axons and axon
terminals in the AOB. We therefore propose that Fpr-rs3-i-Venus
mice not only provide a useful tool for physiological studies
of FPR-rs3+ neurons in the VNO (as described here), but also
for studies of axon targeting and glomerular innervation in the
AOB. While, based on the experimental strategy used here, we
cannot exclude that FPR-rs3+ VSNs additionally express other
vomeronasal receptor genes, this appears unlikely since the neg-
ative feedback signal that ensures gene exclusion in apical VSNs
is also maintained by exogenous expression of another receptor
gene, even an OR (Capello et al., 2009).
The specific biophysical profile of FPR-rs3+ VSNs is a critical
determinant of their sensory input-output function. Passive
membrane properties, such as Rinput, Cmem and τmem, are
therefore crucial functional descriptors of FPR-rs3+ neuron
physiology. Cmem and dendritic geometry together determine
the amplitude of the receptor potential as well as, being inversely
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FIGURE 6 | Voltage-gated Ca2+ currents. (A–D) Representative Ca2+
current traces isolated either biophysically (prepulse inactivation
protocol; (Ai)) or pharmacologically (nifedipine (10 µM; Bi);
ω-conotoxin-GVIA (2 µM; Ci); ω-agatoxin IVA (200 nM; Di). Step
protocols as indicated. Absolute (Aii–Dii) and normalized (Aiii–Diii)
peak current densities are plotted as a function of membrane
depolarization. Activation curves (Aiii–Diii) are fitted according to a
sigmoidal Boltzmann-type equation. Membrane voltage inducing
half-maximal activation (V1/2) as indicated. Data are mean ± SEM;
*p < 0.01, two-tailed Student’s t-test.
proportional, the speed of signal propagation along the dendrite
(Gentet et al., 2000). Cmem values obtained for FPR-rs3+ neurons
are broadly consistent with previously reported data (Liman and
Corey, 1996; Shimazaki et al., 2006; Ukhanov et al., 2007) and do
not differ from values recorded from randomly chosen control
VSNs from wild type C57BL/6 mice. The remarkably high input
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resistance previously reported for VSNs (Liman and Corey, 1996;
Fieni et al., 2003; Shimazaki et al., 2006; Dibattista et al., 2008;
Sagheddu et al., 2010) is shared by FPR-rs3+ neurons. Thus, FPR-
rs3-dependent receptor currents of even a few picoamperes will
be sufficient to trigger action potential discharge. We therefore
propose that the primary signal transduction machinery in
FPR-rs3+ neurons must be balanced by proper gain/offset control
mechanisms to avoid false-positive output. In this context, the
rather narrow tuning range of the input-output function of FPR-
rs3+ neurons (and control VSNs) is noticeable. Frequency coding
accommodates spike rates between 0 and ∼15 Hz that encode
receptor currents ranging to a maximum of ∼25 pA (note that
the “linear” dynamic range of the f -I curve is considerably more
narrow). Similar values have previously been reported (Liman
and Corey, 1996; Ukhanov et al., 2007). The relatively long τmem
values (∼25 ms) we obtained for both FPR-rs3+ and control
neurons ensure that brief stimulatory events will not generate
significant output, in line with the idea that stimulus exchange
in the VNO is relatively slow probably allowing prolonged VSN
receptor-ligand interaction.
Detailed spike waveform analysis revealed rather slow and
broad action potentials in line with previously published results
(Shimazaki et al., 2006; Hagendorf et al., 2009). Moreover, hyper-
polarizing current injection triggers rebound depolarizations
resulting in a pronounced “voltage sag” (Robinson and Siegel-
baum, 2003; Dibattista et al., 2008). Mediated by HCN channels,
we and others observed increasing “sag” amplitudes with mem-
brane potentials becoming more hyperpolarized (Ukhanov et al.,
2007; Dibattista et al., 2008). Thus, active membrane properties
of FPR-rs3+ neurons do not segregate these neurons from the
“general” VSN population.
We used the pufferfish toxin TTX to isolate whole-cell currents
mediated by voltage-gated NaV channels. FPR-rs3+ VSNs express
one or more TTX-sensitive NaV channel isoform(s), i.e., Nav1.1,
1.2, 1.3, 1.4, or 1.7 (Hille, 2001), which exhibit relatively slow
activation upon membrane depolarization >−65 mV with half-
maximal and complete activation at ∼−50 mV and −30 mV,
respectively. Notably, the slope of the steady-state inactivation
curve is relatively shallow, revealing that full channel inactivation
only occurs at positive potentials and, in addition, resulting in
a substantial “window current” that ranges from approximately
−60 mV to−5 mV.
Similar pharmacological approaches were used to isolate
currents mediated by KV and CaV channels, respectively. At
least three different and probably heterogeneous populations of
KV channels were identified according to their sensitivity to
4-AP and different TEA concentrations, respectively (Liman and
Corey, 1996). Interestingly, while 4-AP-sensitive currents lacked
a prominent transient component typical for A-type K+ cur-
rents (Mei et al., 1995; Amberg et al., 2003), this KV channel
population exerted considerable effects on action potential wave-
form. Moreover, these effects on upstroke kinetics (TTP) and
spike width (FDHM/duration) where different between FPR-rs3+
neurons and control VSNs. In addition to NaV and KV chan-
nels, several types of CaV channels were identified in FPR-rs3+
neurons. T-, L-, N-, and P/Q-type ICaV was isolated, either
pharmacologically (L-, N-, P/Q-type) or by prepulse inactivation
(T-type). While T- and L-type ICav in FPR-rs3+ VSNs did not
significantly differ from control neurons, we find that both
N- and P/Q-type currents show somewhat different proper-
ties in FPR-rs3 expressing VSNs. We can only speculate about
the mechanisms that might link FPR-rs3 expression to altered
expression and/or functionality of either N- or P/Q-type CaV
channels. The scope of possible explanations ranges from altered
Cacna1a/Cacna1b transcription by random transgene insertion
to direct binding of Gβ/γ to the α1 subunit of either CaV2
channel (Currie, 2010), complex co-regulation scenarios of, for
example, accessory channel subunits (Neely and Hidalgo, 2014),
or unknown intrinsic properties of a potential subpopulation
of neurons that express FPR-rs3 instead of a “native” recep-
tor. Whatever the mechanistic basis, the interpretation of future
experiments will have to take potential physiological differences
into account, which could arise from transgenic vs. endogenous
expression.
The Fpr-rs3-i-Venus mouse model we introduce and the basic
electrophysiological characterization we performed provide a
foundation for future functional studies of FPR-rs neurophysiol-
ogy. In analogy to FPR signaling in the immune system, current
concepts of FPR-rs function suggest a role as chemoreceptors for
inflammation-associated and pathogen-related compounds (Riv-
ière et al., 2009; Chamero et al., 2011; Bufe et al., 2012). Immune
system FPRs are broadly tuned detectors of either host- or
pathogen-derived inflammatory signals (Le et al., 2002; Migeotte
et al., 2006; He et al., 2014). Somewhat controversial results have
been reported on the tuning profile(s) of recombinantly expressed
vomeronasal FPR-rs proteins (Rivière et al., 2009; Bufe et al.,
2012). Fpr-rs3-i-Venus mice will likely prove useful for studying
FPR-rs3-ligand interaction in homologous cells.
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